PRWCX | TPPAX | PRWCX / TPPAX | |
Total Expense Ratio | 0.71 | 0.62 | 115% |
Annual Report Gross Expense Ratio | 0.73 | 0.80 | 91% |
Fund Existence | 39 years | 9 years | - |
Gain YTD | -3.380 | -2.013 | 168% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2500 | 500000 | 1% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 61.5B | 1.89B | 3,261% |
Annual Yield % from dividends | 2.15 | 2.63 | 82% |
Returns for 1 year | -2.55 | 0.53 | -480% |
Returns for 3 years | 3.11 | 4.66 | 67% |
Returns for 5 years | 22.53 | 16.91 | 133% |
Returns for 10 years | 42.03 | N/A | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
GLO | 4.76 | 0.11 | +2.37% |
Clough Global Opportunities Fund | |||
MARW | 30.42 | 0.20 | +0.65% |
AllianzIM U.S. Large Cp Buffer20 Mar ETF | |||
FTXH | 24.63 | 0.08 | +0.33% |
First Trust Nasdaq Pharmaceuticals ETF | |||
PYLD | 25.87 | 0.04 | +0.15% |
PIMCO Multisector Bond Active ETF | |||
ASA | 29.55 | -0.84 | -2.76% |
ASA Gold AND Precious Metals Limited |